TWC
UTHR icon

TD Waterhouse Canada’s United Therapeutics UTHR Stock Holding History

TD Waterhouse Canada’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$673K Sell
1,228
-68
-5% -$38.3K ﹤0.01% 795
2026
Q1 		$735K Buy
1,296
+76
+6% +$37.8K ﹤0.01% 761
2025
Q4 		$594K Sell
1,220
-161
-12% -$75K ﹤0.01% 661
2025
Q3 		$606K Buy
1,381
+7
+0.5% +$2.35K ﹤0.01% 639
2025
Q2 		$399K Sell
1,374
-1,007
-42% -$301K ﹤0.01% 703
2025
Q1 		$729K Buy
2,381
+504
+27% +$173K 0.01% 577
2024
Q4 		$662K Buy
1,877
+1,682
+863% +$618K 0.01% 575
2024
Q3 		$69.8K Buy
195
+139
+248% +$47K ﹤0.01% 957
2024
Q2 		$17.9K Sell
56
-168
-75% -$44.5K ﹤0.01% 1237
2024
Q1 		$51.2K Hold
224
– – ﹤0.01% 1042
2023
Q4 		$51.5K Hold
224
– – ﹤0.01% 937
2023
Q3 		$49.8K Sell
224
-10
-4% -$2.3K ﹤0.01% 921
2023
Q2 		$51.7K Sell
234
-2
-0.8% -$443 ﹤0.01% 921
2023
Q1 		$53.2K Buy
236
+28
+13% +$6.9K ﹤0.01% 888
2022
Q4 		$56.8K Buy
+208
New +$52.5K ﹤0.01% 875

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

TD Waterhouse Canada's UTHR Position: Q2 2026 in Review

TD Waterhouse Canada reduced its United Therapeutics (UTHR) stake by 5.2% in Q2 2026, selling an estimated $38.3K and leaving 1,228 shares worth $673K. The position accounts for ﹤0.01% of the portfolio, ranked #795.

TD Waterhouse Canada first reported a position in UTHR in Q4 2022 and has held it in 15 quarters since. The position peaked at $735K in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • TD Waterhouse Canada held 1,228 shares of United Therapeutics worth $673K as of Q2 2026.
  • TD Waterhouse Canada sold 68 United Therapeutics shares in Q2 2026, an estimated $38.3K.
  • United Therapeutics made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #795 holding.
  • TD Waterhouse Canada first reported a position in United Therapeutics in Q4 2022 and has held it in 15 quarters since.
  • TD Waterhouse Canada's United Therapeutics position peaked at $735K in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.